Metraipolis › archive › dc_7c25922f2a77

Intravitreal Brolucizumab Use for Retinal Vascular Diseases in Resource-Constrained Settings: A Retrospective Study From Bangladesh — Europe PMC PMID:41853443

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41853443
DOI
10.7759/cureus.103620
License (as archived)
solo-consultazione
Archived
2026-11-05T19:32:25.730Z
SHA-256 of the archived text
231c9378ab1c15f4dfb010deccb681723a33265f1b694b1f5e26f02847ce3c8d
Stable URL of this page
https://metraipolis.com/documento/dc_7c25922f2a77

How to cite

Intravitreal Brolucizumab Use for Retinal Vascular Diseases in Resource-Constrained Settings: A Retrospective Study From Bangladesh — Europe PMC PMID:41853443 — Europe PMC (en), https://europepmc.org/article/MED/41853443 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7c25922f2a77 (Metraipolis archive dc_7c25922f2a77, sha256 231c9378ab1c15f4dfb010deccb681723a33265f1b694b1f5e26f02847ce3c8d)
BibTeX
@misc{dc7c25922f2a77,
  title = {Intravitreal Brolucizumab Use for Retinal Vascular Diseases in Resource-Constrained Settings: A Retrospective Study From Bangladesh — Europe PMC PMID:41853443},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41853443},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7c25922f2a77; sha256 231c9378ab1c15f4dfb010deccb681723a33265f1b694b1f5e26f02847ce3c8d},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41853443. Agents can read the archived copy with the MCP tool read_document.